Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics

Xtant Medical Holdings, Inc. (XTNT): $0.64

0.03 (+4.30%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add XTNT to Watchlist
Sign Up

Industry: Medical - Devices & Equipment

Industry

NR

Ranked

#60 of 182

in industry

XTNT Price/Volume Stats

Current price $0.64 52-week high $1.20
Prev. close $0.61 52-week low $0.43
Day low $0.61 Volume 3,708
Day high $0.65 Avg. volume 41,384
50-day MA $0.63 Dividend yield N/A
200-day MA $0.66 Market Cap 69.28M

XTNT Stock Price Chart Interactive Chart >

XTNT Stock Summary

  • XTANT MEDICAL HOLDINGS INC's market capitalization of $72,961,022 is ahead of only 18.28% of US-listed equities.
  • Of note is the ratio of XTANT MEDICAL HOLDINGS INC's sales and general administrative expense to its total operating expenses; 83.54% of US stocks have a lower such ratio.
  • XTANT MEDICAL HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -18.65%, greater than the shareholder yield of only 19% of stocks in our set.
  • Stocks that are quantitatively similar to XTNT, based on their financial statements, market capitalization, and price volatility, are NVFY, BARK, IVDA, IDXG, and HURC.
  • XTNT's SEC filings can be seen here. And to visit XTANT MEDICAL HOLDINGS INC's official web site, go to www.xtantmedical.com.

XTNT Valuation Summary

  • XTNT's price/sales ratio is 1.1; this is 78.43% lower than that of the median Healthcare stock.
  • Over the past 157 months, XTNT's EV/EBIT ratio has gone down 793.3.

Below are key valuation metrics over time for XTNT.

Stock Date P/S P/B P/E EV/EBIT
XTNT 2023-05-23 1.1 2.1 -8.2 -13.3
XTNT 2023-05-22 1.1 2.1 -8.2 -13.2
XTNT 2023-05-19 1.1 2.1 -8.3 -13.5
XTNT 2023-05-18 1.0 2.0 -7.8 -12.8
XTNT 2023-05-17 1.1 2.1 -8.2 -13.3
XTNT 2023-05-16 1.1 2.1 -8.2 -13.2

XTNT Growth Metrics

    Its 4 year price growth rate is now at -88.13%.
  • The 5 year price growth rate now stands at -88.13%.
  • The 3 year revenue growth rate now stands at -21.57%.
XTNT's revenue has moved down $8,014,000 over the prior 33 months.

The table below shows XTNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 56.668 -2.63 -8.559
2022-06-30 55.983 -1.492 -8.01
2022-03-31 55.681 0.742 -7.033
2021-12-31 55.263 0.439 -4.849
2021-09-30 55.309 0.932 -3.272
2021-06-30 55.548 1.787 -2.828

Xtant Medical Holdings, Inc. (XTNT) Company Bio


Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.


XTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

XTNT Latest Social Stream


Loading social stream, please wait...

View Full XTNT Social Stream

Latest XTNT News From Around the Web

Below are the latest news stories about XTANT MEDICAL HOLDINGS INC that investors may wish to consider to help them evaluate XTNT as an investment opportunity.

Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors

BELGRADE, Mont., May 18, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Lori Mitchell-Keller to the Company's Board of Directors effective May 16, 2023. Ms. Mitchell-Keller will serve as a member of the Compensation and Audit Committees of the Board of Directors. “We are pleased to welcome Lori to our Board, marking another high

Yahoo | May 18, 2023

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call Transcript

Xtant Medical Holdings, Inc. (AMEX:XTNT) Q1 2023 Earnings Call Transcript May 6, 2023 Operator: Greetings. You’re welcome Xtant Medical’s Q1 2023 financial results call. . As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Matt Steinberg of Lazar FINN Partners. Please go ahead. Matt […]

Yahoo | May 9, 2023

Xtant Medical Announces First Quarter 2023 Revenue Growth of 38% and Full Year 2023 Revenue Guidance

Initiates Annual Revenue Guidance of $73 Million - $75 Million in Full Year 2023 BELGRADE, Mont., May 04, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2023. The Company also introduced financial guidance for the full year 2023. “Highlighted by solid revenue growth and the Cofle

Yahoo | May 4, 2023

Xtant Medical to Issue First Quarter 2023 Financial Results on May 4, 2023

BELGRADE, Mont., April 27, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2023, before the open of the financial markets on Thursday, May 4, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call

Yahoo | April 27, 2023

Q4 2022 Xtant Medical Holdings Inc Earnings Call

Q4 2022 Xtant Medical Holdings Inc Earnings Call

Yahoo | March 8, 2023

Read More 'XTNT' Stories Here

XTNT Price Returns

1-mo 3.23%
3-mo -45.76%
6-mo 6.93%
1-year 11.28%
3-year -47.97%
5-year -87.99%
YTD -3.03%
2022 17.86%
2021 -53.18%
2020 -25.24%
2019 -0.62%
2018 -76.46%

Continue Researching XTNT

Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:

Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!